164 related articles for article (PubMed ID: 16923423)
1. C-reactive protein and risk of heart failure. The Rotterdam Study.
Kardys I; Knetsch AM; Bleumink GS; Deckers JW; Hofman A; Stricker BH; Witteman JC
Am Heart J; 2006 Sep; 152(3):514-20. PubMed ID: 16923423
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.
van Vark LC; Kardys I; Bleumink GS; Knetsch AM; Deckers JW; Hofman A; Stricker BH; Witteman JC
Eur Heart J; 2006 Oct; 27(19):2346-52. PubMed ID: 16952920
[TBL] [Abstract][Full Text] [Related]
3. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
[TBL] [Abstract][Full Text] [Related]
4. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
5. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.
Kardys I; de Maat MP; Uitterlinden AG; Hofman A; Witteman JC
Eur Heart J; 2006 Jun; 27(11):1331-7. PubMed ID: 16682383
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
10. Inflammation biomarkers and near-term death in older men.
Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
[TBL] [Abstract][Full Text] [Related]
11. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Koenig W; Khuseyinova N; Baumert J; Thorand B; Loewel H; Chambless L; Meisinger C; Schneider A; Martin S; Kolb H; Herder C
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2745-51. PubMed ID: 17008587
[TBL] [Abstract][Full Text] [Related]
12. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study.
van Dijk EJ; Prins ND; Vermeer SE; Vrooman HA; Hofman A; Koudstaal PJ; Breteler MM
Circulation; 2005 Aug; 112(6):900-5. PubMed ID: 16061741
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study).
Mukamal KJ; Tolstrup JS; Friberg J; Grønbaek M; Jensen G
Am J Cardiol; 2006 Jul; 98(1):75-81. PubMed ID: 16784925
[TBL] [Abstract][Full Text] [Related]
16. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
[TBL] [Abstract][Full Text] [Related]
19. Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men.
Nakhai Pour HR; Grobbee DE; Muller M; van der Schouw YT
Clin Endocrinol (Oxf); 2007 Mar; 66(3):394-8. PubMed ID: 17302874
[TBL] [Abstract][Full Text] [Related]
20. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
